Xenetic Biosciences Inc. (NASDAQ:XBIO) went up by 10.95% from its latest closing price compared to the recent 1-year high of $5.85. The company’s stock price has collected 24.88% of gains in the last five trading sessions. Press Release reported on 01/05/21 that Xenetic Biosciences, Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
Is It Worth Investing in Xenetic Biosciences Inc. (NASDAQ :XBIO) Right Now?
Plus, the 36-month beta value for XBIO is at 2.51. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Xenetic Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $3.75. XBIO currently public float of 5.57M and currently shorts hold a 9.48% ratio of that float. Today, the average trading volume of XBIO was 3.60M shares.
XBIO’s Market Performance
XBIO stocks went up by 24.88% for the week, with a monthly drop of -15.30% and a quarterly performance of 179.69%, while its annual performance rate touched 69.94%. The volatility ratio for the week stands at 14.22% while the volatility levels for the past 30 days are set at 12.42% for Xenetic Biosciences Inc.. The simple moving average for the period of the last 20 days is 29.06% for XBIO stocks with a simple moving average of 143.22% for the last 200 days.
Analysts’ Opinion of XBIO
Many brokerage firms have already submitted their reports for XBIO stocks, with Maxim Group repeating the rating for XBIO by listing it as a “Buy.” The predicted price for XBIO in the upcoming period, according to Maxim Group is $2.50 based on the research report published on January 08th of the previous year 2020.
XBIO Trading at 87.53% from the 50-Day Moving Average
After a stumble in the market that brought XBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.10% of loss for the given period.
Volatility was left at 12.42%, however, over the last 30 days, the volatility rate increased by 14.22%, as shares surge +17.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +221.52% upper at present.
During the last 5 trading sessions, XBIO rose by +24.88%, which changed the moving average for the period of 200-days by +272.92% in comparison to the 20-day moving average, which settled at $2.10. In addition, Xenetic Biosciences Inc. saw 31.62% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for XBIO
Current profitability levels for the company are sitting at:
- -56272.41 for the present operating margin
The net margin for Xenetic Biosciences Inc. stands at -74856.59. The total capital return value is set at -70.75, while invested capital returns managed to touch -94.19. Equity return is now at value -76.70, with -62.10 for asset returns.
Based on Xenetic Biosciences Inc. (XBIO), the company’s capital structure generated 0.12 points at debt to equity in total, while total debt to capital is 0.12.
When we switch over and look at the enterprise to sales, we see a ratio of -365.50, with the company’s debt to enterprise value settled at 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.84.